Authored By: Sarah
10 Feb 2023

Active Pharmaceutical Ingredients Market Share, Segments, Trends, Growth, and Geography- Analysis, and Forecast 2021-2025

The active pharmaceutical ingredients (API) market share is forecast to reach USD 64.53 billion, after growing at a CAGR of 6.1% during 2020-2025. The evolving API manufacturing scenario in developing countries is analyzed to boost the active pharmaceutical ingredients (API) market growth. Moreover, the increasing geriatric population is the major trend enhancing the overall market demand for active pharmaceutical ingredients (API) during the forecast period.   

Get a snapshot of the active pharmaceutical ingredients (API) market analysis: Unlock the Sample Report 

Browse Technavio's 120-page report and in-depth TOC on "Active Pharmaceutical Ingredients Market by manufacturing type (captive APIs and contract APIs) and geographic (APAC, North America, Europe, and ROW).

View detailed Table of Contents Here: https://www.technavio.com/report/active-pharmaceutical-ingredients-market-industry-analysis

Active Pharmaceutical Ingredients Market Share, Segments, Trends, Growth, and Geography- Analysis, and Forecast 2021-2025

Manufacturing type: 

  • Captive APIs: The API market share growth by the captive APIs will be significant during the forecast period. There is a huge focus on increasing the accessibility to affordable healthcare services, and this has led to increased demand for access to low-cost medicines, in turn inducing the demand for low-cost APIs for manufacturing finished drugs.

  • Contract APIs

Geography: 

  • APAC: 66% of the market's growth will originate from APAC during the forecast period. The major reason for China's ability to capture the global API market is the cheap and cost-effective production of APIs, resulting from its large-scale manufacturing which will facilitate the active pharmaceutical ingredients market growth in APAC over the forecast period.

  • North America

  • Europe

  • ROW

Key Takeaways: 

  • The active pharmaceutical ingredients (API) market size will witness a YOY Growth Rate of 5.80% in 2021.  

  • The high investment cost and concern of huge financial loss will be a major challenge for the active pharmaceutical ingredients (API) market during the forecast period. 

  • Major key active pharmaceutical ingredients (API) market players include Amneal Pharmaceuticals Inc., Cadila Healthcare Ltd., Dr. Reddy's Laboratories Ltd., GlaxoSmithKline Plc, Koninklijke DSM NV, Mylan NV, Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.  

  • The report illustrates the lifecycle of the market, focusing on the adoption rates of the major regions such as APAC, North America, Europe, and ROW. 

Download the PDF sample report for highlights on the market size, growth momentum, regional growth opportunities, vendor analysis, and other factors influencing the market growth. 

Key data covered in the Active Pharmaceutical Ingredients Market report 

  • Precise market size estimation during the forecast period 2021-2025.  

  • CAGR of the active pharmaceutical ingredients (API) market forecast during 2021-2025.  

  • Market-level data on units, average selling prices, and values of the active pharmaceutical ingredients (API) market share.  

  • Prediction of the upcoming trends, drivers, and factors that challenge the growth of the active pharmaceutical ingredients (API) market.  

  • Active pharmaceutical ingredients (API) industry growth across APAC, North America, Europe, and ROW.

Read News Read Less
Interested in this report?
Get your sample now!
Technavio